Last reviewed · How we verify

NCT04000932

Platelet Rich Plasma in Carpal Tunnel Syndrome

Status unknown Phase 3 Last updated 28 June 2019
What this trial tests

Phase 3 trial testing Local platelet rich plasma (PRP) injection-T-Lab PRP kit in Carpal Tunnel Syndrome in 84 participants. Status unknown.

Timeline
15 July 2018
Primary endpoint
30 December 2019
30 January 2020

Quick facts

Lead sponsorBaskent University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment84
Start date15 July 2018
Primary completion30 December 2019
Estimated completion30 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 25 to 75, female only, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of local platelet rich plasma injection therapy in patients with mild to moderate idiopathic carpal tunnel syndrome (CTS) with clinical and electrophysiological parameters. Also the effect of platelet rich plasma and local steroid injection will be compared.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effectiveness of single-dose blinded platelet-rich plasma (PRP) vs. corticosteroid injection in mild-to-moderate carpal tunnel syndrome: A prospective, randomized, double blind study.
    Şenlikci HB, Afşar Sİ, Coşar SN, Kurtcebe AN, et al · · 2025 · PMID 40325784 · DOI 10.1016/j.jbmt.2025.01.057

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing